(MedPage Today) — MINNEAPOLIS — The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D trial.
The Integra CCM-D had…
Source link : https://www.medpagetoday.com/meetingcoverage/hfsa/117687
Author :
Publish date : 2025-09-29 14:26:00
Copyright for syndicated content belongs to the linked Source.
